LRRK2, a major modulator of neuroinflammation involved in the pathogenesis of Parkinson’s disease, is upregulated in both depressive (logFC = 0.56) and VDD (logFC = 2.57) patients [47,48]. This evidence concerns the gene LRRK2 and Parkinson disease.